Report of the Brain Tumor Progress Review Group

摘要

It is a great pleasure to submit this Report of the Brain Tumor Progress ReviewGroup (BT-PRG) to the Director and Advisory Committee to the Director of the National Cancer Institute (NCI), and to the Director and National Advisory Committee to the Director of the National Cancer Institute (NCI). And to the Director and National Advisory Neurological Disorders and Stroke Council of the National Institute of Neurological Disorders and Stroke (NINDS). At the beginning of 2000, the BT-PRG accepted the charge of Dr. Richard Klausner, Director of the NCI, and Dr. Gerald Fischback, Director of the NINDS, to develop a national plan for the next decade of brain tumor research. Although this is the 4th in the series of PRGs, it is the first to be sponsored by 2 institutes, reflecting the importance of both cancer biology and neurobiology to the brain tumor field. The expertise and efficiency of the BT-PRG members and of the participants of the BT-PRG Roundtable Meeting have produced this exciting report in a ten-month period, reflecting the energy and enthusiasm of the clinical, research, industrial and advocacy communities for finding a cure for brain tumors. The Report of the Brain Tumor Progress Review Group highlights the scientific research priorities that represent the next steps toward understanding the biological basis of brain tumors, and toward developing effective therapies for brain tumors.